ED files chargesheet against ex-HP CM's son

Agencies
July 21, 2018

New Delhi, Jul 21: The Enforcement Directorate (ED) on Saturday filed a chargesheet in a Delhi court against Virbhadra Singh's son Vikramaditya in a money laundering case also involving the former Himachal Pradesh chief minister.

Special Judge Arvind Kumar fixed the matter for consideration on July 24, when he will decide on whether to take cognisance of the final report.

The chargesheet, filed by special public prosecutors Nitesh Rana and N K Matta, also named Managing Director of Tarani Infrastructure Vakamulla Chandrasekhar and one Ram Prakash Bhatia as an accused.

Both Chandrasekhar and Bhatia are also an accused in a CBI case related to the matter, along with Virbhadra Singh, his wife Pratibha Singh and others.

Besides 83-year-old Singh and his 62-year-old wife, the others named in the ED chargesheet, filed through advocate A R Aditya, are Universal Apple Associate owner Chunni Lal Chauhan, Life Insurance Corporation (LIC) agent Anand Chauhan and two other co-accused Prem Raj and Lawan Kumar Roach.

Anand Chauhan, arrested on July 9, 2016, by the ED under relevant provisions of the Prevention of Money Laundering Act, 2002, was granted bail on January 2 in the case.

In a separate case filed by the Central Bureau of Investigation in relation to the matter, the former Himachal Pradesh chief minister, his wife and Chauhan were chargesheeted along with others.

The couple, who have not been arrested so far in any of the two cases, and the other accused are facing trial in the CBI case.

The other accused in the CBI case are Chunni Lal Chauhan, stamp paper vendor Joginder Singh Ghalta, Managing Director of Tarani Infrastructure Vakamulla Chandrasekhar, and co-accused Lawan Kumar Roach, Prem Raj and Ram Prakash Bhatia.

The CBI had claimed that Virbhadra Singh had amassed assets worth around Rs 10 crore which were disproportionate to his total income during his tenure as a Union minister.

The matter was transferred by the Supreme Court to the Delhi High Court which, on April 6, 2016, asked the CBI not to arrest Singh and directed him to join the probe.

On November 5 last year, the apex court transferred Singh's plea from the Himachal Pradesh High Court to the Delhi High Court, saying it was not expressing any opinion on the merits of the case, but "simply" transferring the petition "in the interest of justice and to save the institution (judiciary) from any embarrassment".

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 22,2020

Thiruvananthapuram, Apr 22: Eleven more people tested positive for COVID-19 in Kerala with totalpositive cases in the State touching 437on Wednesday.

Two house surgeonsof the Kozhikode Medical college are among those who have tested positive for the virus.

The two had travelled outside the state,Chief Minister Pinarayi Vijayan told reporters.

Kannur reported seven cases, Kozhikode two, while one case each was reported from the districts of Kottayam and Malappuram.

Only one person tested negative.

The state has 127 active cases and 29,000 people are under observation, including 346 in hospitals.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 27,2020

New Delhi, Jan 27: The government on Monday issued the preliminary information memorandum for 100 per cent stake sale in national carrier Air India. As part of the strategic disinvestment, Air India would also sell 100 per cent stake in low cost airline Air India Express and 50 per cent shareholding in joint venture AISATS, as per the bid document issued on Monday.

Management control of the airline would also be transferred to the successful bidder.

The government has set March 17 as the deadline for submitting the Expression of Interest (EoI).

EY is the transaction adviser for Air India disinvestment process.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.